Resverlogix to Participate in Leading Scientific Conferences
Presentations will Showcase Research by Resverlogix Scientists, Advancing our Understanding of Epigenetics in Chronic Diseases CALGARY, Alberta, Oct. 29, 2021...
Day: October 29, 2021
Bioventus Completes the Acquisition of Misonix
DURHAM, N.C., Oct. 29, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in...
Biomerica Launches New Website for Its Aware® Breast Exam Device
Simple at-home breast exam device provides results within minutesStudies show increase in Breast Exam SensitivityIRVINE, Calif. , Oct. 29, 2021...
Catalyst Biosciences Announces CFI Variant Presentations at Two Upcoming Scientific Conferences
SOUTH SAN FRANCISCO, Calif., Oct. 29, 2021 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO) today announced that Grant Blouse,...
Oncternal Therapeutics to Provide Business Update and Report Third Quarter 2021 Financial Results
SAN DIEGO, Oct. 29, 2021 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the...
Immutep Receives Positive EMA Scientific Advice for Further Clinical Development of Efti in MBC Including Phase III
Positive feedback for the general clinical development program including the planned registrational Phase III trial in metastatic breast cancer (MBC)Other...
Independence Blue Cross and Podimetrics Collaborate to Prevent Diabetic Amputations
PHILADELPHIA and SOMERVILLE, Mass., Oct. 29, 2021 (GLOBE NEWSWIRE) -- Independence Blue Cross (Independence) and Podimetrics, a virtual care management...
Leader in Corporate Development and Strategy Joins Mesa Labs Board of Directors
LAKEWOOD, Colo., Oct. 29, 2021 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) announced the appointment of Shiraz Ladiwala to its...
Nova Leap Health Corp. Announces Execution of Definitive Agreement and Expansion to Southeastern U.S.
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, Oct. 29, 2021...
Trading by management and close relations of management
Please read the full announcement in PDF Attachment 2021_48_Trading_by_management
Cronos Group Chief Innovation Officer Dr. Todd Abraham to Retire
Arye Weigensberg Named Interim Head of Research and Development Search to Identify Permanent Successor Well Underway TORONTO, Oct. 29, 2021...
Jushi Holdings Inc. to Open its 26th Store Nationwide and 2nd BEYOND / HELLO™ Retail Location in Virginia
BEYOND / HELLO™ Sterling to Open On Tuesday, November 2nd at 10:00 a.m., BEYOND / HELLO™ Sterling will begin serving...
Mydecine to Participate in Wonderland: Miami on November 8-9, 2021
DENVER, Oct. 29, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company’),...
Rapid Micro Biosystems to Present at Stifel 2021 Virtual Healthcare Conference
LOWELL, Mass., Oct. 29, 2021 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (“Rapid Micro” or the “Company”), an...
Cytokinetics Announces Preclinical Data Relating to CK-3828136 Presented at the 2021 Medicinal Chemistry Gordon Research Conference
SOUTH SAN FRANCISCO, Calif., Oct. 29, 2021 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that preclinical data relating...
Cerner Reports Third Quarter 2021 Results
Delivers Strong Results Across Key MetricsGAAP Operating Margin and Diluted EPS Lower; Adjusted Operating Margin and Adjusted Diluted EPS Both...
HEXO Reports Fourth Quarter and Fiscal Year 2021 Financial Results Highlighting Strong Growth
Total net sales growth of 71% quarter-over-quarter and 43% from Q4’20, marking HEXO's best quarter of sales to date.Total Q4’21...
IRADIMED CORPORATION Announces Third Quarter 2021 Financial Results
Reports third quarter 2021 revenue of $10.9 million, GAAP diluted EPS of $0.20 and non-GAAP diluted EPS of $0.23Increases full-year...
Athira Pharma to Host Educational Webinar on the Clinical Applications of ERP P300
Neurologist Dr. John Michael Olichney to discuss utility of P300 to assess cognitive function Webinar to be held Friday, Nov....
Talaris Therapeutics Announces Initiation of Phase 2 Clinical Trial of FCR001 in Delayed Tolerance Induction
FREEDOM-2 trial will evaluate the potential for the company’s investigational allogeneic cell therapy, FCR001, to induce durable immune tolerance in...
